1. Home
  2. APLS vs PAGP Comparison

APLS vs PAGP Comparison

Compare APLS & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • PAGP
  • Stock Information
  • Founded
  • APLS 2009
  • PAGP 2013
  • Country
  • APLS United States
  • PAGP United States
  • Employees
  • APLS N/A
  • PAGP N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • PAGP Natural Gas Distribution
  • Sector
  • APLS Health Care
  • PAGP Energy
  • Exchange
  • APLS Nasdaq
  • PAGP Nasdaq
  • Market Cap
  • APLS 2.9B
  • PAGP 3.5B
  • IPO Year
  • APLS 2017
  • PAGP 2013
  • Fundamental
  • Price
  • APLS $20.39
  • PAGP $17.90
  • Analyst Decision
  • APLS Buy
  • PAGP Hold
  • Analyst Count
  • APLS 19
  • PAGP 8
  • Target Price
  • APLS $32.83
  • PAGP $19.86
  • AVG Volume (30 Days)
  • APLS 3.4M
  • PAGP 1.5M
  • Earning Date
  • APLS 10-30-2025
  • PAGP 11-05-2025
  • Dividend Yield
  • APLS N/A
  • PAGP 8.51%
  • EPS Growth
  • APLS N/A
  • PAGP 11.06
  • EPS
  • APLS 0.36
  • PAGP 0.95
  • Revenue
  • APLS $1,016,397,000.00
  • PAGP $46,917,000,000.00
  • Revenue This Year
  • APLS $25.39
  • PAGP N/A
  • Revenue Next Year
  • APLS N/A
  • PAGP $11.23
  • P/E Ratio
  • APLS $56.77
  • PAGP $56.96
  • Revenue Growth
  • APLS 42.11
  • PAGP N/A
  • 52 Week Low
  • APLS $16.10
  • PAGP $16.61
  • 52 Week High
  • APLS $35.72
  • PAGP $22.31
  • Technical
  • Relative Strength Index (RSI)
  • APLS 39.49
  • PAGP 56.48
  • Support Level
  • APLS $18.93
  • PAGP $16.89
  • Resistance Level
  • APLS $30.48
  • PAGP $17.72
  • Average True Range (ATR)
  • APLS 1.29
  • PAGP 0.32
  • MACD
  • APLS -0.37
  • PAGP 0.08
  • Stochastic Oscillator
  • APLS 13.94
  • PAGP 94.86

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests

Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.

Share on Social Networks: